The mid-size pharmaceutical market is expected to grow from US$ 6,51,349.9 million in 2021 to US$ 10,00,584.3 million by 2028.
The increasing prevalence of chronic diseases and the rising number of products launches & approvals drive the market growth. However, cutthroat competition among market players hampers the mid-size pharmaceutical market growth.
Revenue, therapy area, R&D expenditure, and reach are among the critical segments of the global pharmaceutical industry. Mid-size pharmaceutical is among the three categories of the pharmaceutical industry. It emphasizes the development of generic drugs and the development of rare disease therapies. The mid-sized pharmaceutical companies have their revenue in the range of US$ 1 billion to US$ 10 billion. The increasing prevalence of chronic diseases, rapidly rising elderly population, and the surging number of products launches & approvals is expected to aid the mid-size pharmaceutical market growth.
The aging population and changing social behavior contribute to the steady increase in common and costly long-term health problems. With the accelerating urbanization, people are adopting a sedentary lifestyle, which boosts the rates of obesity and cases of illnesses, such as diabetes. According to the World Health Organization, the prevalence of chronic diseases is projected to increase by 57% by 2026. Emerging markets will be hit hardest, as population growth is expected to be the strongest in developing countries. Increasing demand for health care systems due to the rising incidence of chronic illnesses has become a major concern.
Diabetes is one of the biggest global health problems of the 21st century. Every year, many people develop this condition, causing life-changing complications. According to the International Diabetes Federation (IDF), the number of people with diabetes in North America was about 46 million in 2019 and is projected to increase to 62 million by 2045. The increase in disease prevalence would be about 35% during the predicted period. Pandemics such as COVID-19, have tested the rate at which infections unfold throughout the globe. Pandemics exert periodic and enormous disruptive strains on fitness systems. Healthcare establishments across the world want to be geared up to collectively comprise outbreaks once they occur. Thus, the increasing prevalence of chronic disorders boosts the mid-size pharmaceutical market growth.
Based on type, the mid-size pharmaceutical market is segmented into prescription and over-the-counter. In 2021, the over-the-counter segment held a larger market share. Furthermore, it is expected to register a higher CAGR of 6.7% during the forecast period.
Based on drug development type, the mid-size pharmaceutical market is segmented into in-house and outsource. In 2021, the outsource segment held a larger share of the market. It is expected to register a higher CAGR of 6.7% during 2021-2028.
Based on formulation, the mid-size pharmaceutical market is segmented into tablets & capsules, injectables, sprays, and other formulations. In 2021, the tablets & capsules segment held the largest share of the market. It is expected to register the highest CAGR of 7.1% during 2021-2028.
Based on therapy area, the mid-size pharmaceutical market is segmented into cardiovascular diseases, pain management, diabetes, cancer, and other conditions. In 2021, the diabetes segment held the largest share of the market. On the other hand, the cancer segment is expected to register the highest CAGR of 7.0% during 2021-2028.
The World Health Organization (WHO); Economic Co-operation and Development (OECD); Brazilian Ministry of Economy; GLOBOCAN; Centers for Disease Control and Prevention (CDC); United Nations International Children's Emergency Fund (UNICEF); and US Census Bureau are among the major secondary sources referred to while preparing the report on the mid-size pharmaceutical market.
The increasing prevalence of chronic diseases and the rising number of products launches & approvals drive the market growth. However, cutthroat competition among market players hampers the mid-size pharmaceutical market growth.
Revenue, therapy area, R&D expenditure, and reach are among the critical segments of the global pharmaceutical industry. Mid-size pharmaceutical is among the three categories of the pharmaceutical industry. It emphasizes the development of generic drugs and the development of rare disease therapies. The mid-sized pharmaceutical companies have their revenue in the range of US$ 1 billion to US$ 10 billion. The increasing prevalence of chronic diseases, rapidly rising elderly population, and the surging number of products launches & approvals is expected to aid the mid-size pharmaceutical market growth.
The aging population and changing social behavior contribute to the steady increase in common and costly long-term health problems. With the accelerating urbanization, people are adopting a sedentary lifestyle, which boosts the rates of obesity and cases of illnesses, such as diabetes. According to the World Health Organization, the prevalence of chronic diseases is projected to increase by 57% by 2026. Emerging markets will be hit hardest, as population growth is expected to be the strongest in developing countries. Increasing demand for health care systems due to the rising incidence of chronic illnesses has become a major concern.
Diabetes is one of the biggest global health problems of the 21st century. Every year, many people develop this condition, causing life-changing complications. According to the International Diabetes Federation (IDF), the number of people with diabetes in North America was about 46 million in 2019 and is projected to increase to 62 million by 2045. The increase in disease prevalence would be about 35% during the predicted period. Pandemics such as COVID-19, have tested the rate at which infections unfold throughout the globe. Pandemics exert periodic and enormous disruptive strains on fitness systems. Healthcare establishments across the world want to be geared up to collectively comprise outbreaks once they occur. Thus, the increasing prevalence of chronic disorders boosts the mid-size pharmaceutical market growth.
Based on type, the mid-size pharmaceutical market is segmented into prescription and over-the-counter. In 2021, the over-the-counter segment held a larger market share. Furthermore, it is expected to register a higher CAGR of 6.7% during the forecast period.
Based on drug development type, the mid-size pharmaceutical market is segmented into in-house and outsource. In 2021, the outsource segment held a larger share of the market. It is expected to register a higher CAGR of 6.7% during 2021-2028.
Based on formulation, the mid-size pharmaceutical market is segmented into tablets & capsules, injectables, sprays, and other formulations. In 2021, the tablets & capsules segment held the largest share of the market. It is expected to register the highest CAGR of 7.1% during 2021-2028.
Based on therapy area, the mid-size pharmaceutical market is segmented into cardiovascular diseases, pain management, diabetes, cancer, and other conditions. In 2021, the diabetes segment held the largest share of the market. On the other hand, the cancer segment is expected to register the highest CAGR of 7.0% during 2021-2028.
The World Health Organization (WHO); Economic Co-operation and Development (OECD); Brazilian Ministry of Economy; GLOBOCAN; Centers for Disease Control and Prevention (CDC); United Nations International Children's Emergency Fund (UNICEF); and US Census Bureau are among the major secondary sources referred to while preparing the report on the mid-size pharmaceutical market.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Mid-Size Pharmaceutical - By Type
1.3.2 Global Mid-Size Pharmaceutical - By Drug Development Type
1.3.3 Global Mid-Size Pharmaceutical - By Formulation
1.3.4 Global Mid-Size Pharmaceutical - By Therapy Area
1.3.5 Global Mid-Size Pharmaceutical - By Geography
2. Mid-Size Pharmaceutical - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Mid-Size Pharmaceutical - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East & Africa - PEST Analysis
4.2.5 South & Central America - PEST Analysis
4.3 Expert Opinion
5. Mid-Size Pharmaceutical Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Disorders
5.1.2 Increasing Product Approval and Launches
5.2 Market Restraints
5.2.1 Cutthroat Competition among Market Players
5.3 Market Opportunities
5.3.1 Rising Number of Healthcare Start-ups
5.4 Future Trends
5.4.1 Greater Focus on R & amp;D
5.5 Impact Analysis
6. Mid-Size Pharmaceutical Market - Global Analysis
6.1 Global Mid-Size Pharmaceutical Market Revenue Forecast And Analysis
6.1.1 Global Mid-Size Pharmaceutical Market Revenue Forecast And Analysis
6.1.2 Global Mid-Size Pharmaceutical Market - Market Potential Analysis, By Region
6.2 Market Positioning Analysis Of Key Players In Mid-Size Pharmaceutical Market
6.2.1 Company Analysis
6.2.2 Growth Strategy Analysis
6.2.3 Performance Of Key Players
6.2.3.1 Regeneron Pharmaceuticals, Inc.
6.2.3.2 DAIICHI SANKYO COMPANY LIMITED
7. Global Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028 - by Type
7.1 Overview
7.2 Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028)
7.3 Prescription
7.3.1 Overview
7.3.2 Prescription: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Over-the-Counter (OTC)
7.4.1 Overview
7.4.2 Over-the-Counter: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
8. Mid-Size Pharmaceutical Market Analysis - By Drug Development Type
8.1 Overview
8.2 Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028)
8.3 In-House
8.3.1 Overview
8.3.2 In-House: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Outsource
8.4.1 Overview
8.4.2 Outsource: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
9. Mid-Size Pharmaceutical Market - By Formulation
9.1 Overview
9.2 Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%)
9.3 Tablets and Capsules
9.3.1 Overview
9.3.2 Tablets and Capsules: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Injectables
9.4.1 Overview
9.4.2 Injectables: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Sprays
9.5.1 Overview
9.5.2 Sprays: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Other Formulations
9.6.1 Overview
9.6.2 Others: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
10. Mid-Size Pharmaceutical Market - By Therapy Class
10.1 Overview
10.2 Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%)
10.3 Cardiovascular Diseases
10.3.1 Overview
10.3.2 Cardiovascular Diseases: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Pain Management
10.4.1 Overview
10.4.2 Pain Management: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Diabetes
10.5.1 Overview
10.5.2 Diabetes: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
10.6 Cancer
10.6.1 Overview
10.6.2 Cancer: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
10.7 Other Diseases
10.7.1 Overview
10.7.2 Other Diseases: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11. Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 - Geographical Analysis
11.1 North America: Mid-Size Pharmaceutical Market
11.1.1 Overview
11.1.2 North America: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.1.3 North America: Mid-Size Pharmaceutical Market, by Type, 2019 - 2028 (US$ Million)
11.1.4 North America: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019 - 2028 (US$ Million)
11.1.5 North America: Mid-Size Pharmaceutical Market, by Formulation, 2019 - 2028 (US$ Million)
11.1.6 North America: Mid-Size Pharmaceutical Market, by Therapy Area, 2019 - 2028 (US$ Million)
11.1.7 North America: Mid-Size Pharmaceutical Market, by Country, 2021 & 2028 (%)
11.1.7.1 US: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.1 Overview
11.1.7.1.2 US: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.3 US: Mid-Size Pharmaceutical Market, by Type, 2019 - 2028 (US$ Million)
11.1.7.1.4 US: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019 - 2028 (US$ Million)
11.1.7.1.5 US: Mid-Size Pharmaceutical Market, by Formulation, 2019 - 2028 (US$ Million)
11.1.7.1.6 US: Mid-Size Pharmaceutical Market, by Therapy Area, 2019 - 2028 (US$ Million)
11.1.7.2 Canada: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.1 Overview
11.1.7.2.2 Canada: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.3 Canada: Mid-Size Pharmaceutical Market, by Type, 2019 - 2028 (US$ Million)
11.1.7.2.4 Canada: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019 - 2028 (US$ Million)
11.1.7.2.5 Canada: Mid-Size Pharmaceutical Market, by Formulation, 2019 - 2028 (US$ Million)
11.1.7.2.6 Canada: Mid-Size Pharmaceutical Market, by Therapy Area, 2019 - 2028 (US$ Million)
11.1.7.3 Mexico: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.1 Overview
11.1.7.3.2 Mexico: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.3 Mexico: Mid-Size Pharmaceutical Market, by Type, 2019 - 2028 (US$ Million)
11.1.7.3.4 Mexico: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019 - 2028 (US$ Million)
11.1.7.3.5 Mexico: Mid-Size Pharmaceutical Market, by Formulation, 2019 - 2028 (US$ Million)
11.1.7.3.6 Mexico: Mid-Size Pharmaceutical Market, by Therapy Area, 2019 - 2028 (US$ Million)
11.2 Europe: Mid-Size Pharmaceutical Market
11.2.1 Overview
11.2.2 Europe: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.2.3 Europe: Mid-Size Pharmaceutical Market, by Type - Revenue and Forecast to 2028 (US$ Million)
11.2.4 Europe: Mid-Size Pharmaceutical Market, by Drug Development Type - Revenue and Forecast to 2028 (US$ Million)
11.2.4.1 Europe: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
11.2.4.2 Europe: Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
11.2.5 Europe: Mid-Size Pharmaceutical Market, by Country, 2021 & 2028 (%)
11.2.5.1 Germany: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.2.5.1.1 Overview
11.2.5.1.2 Germany: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.2.5.1.3 Germany: Mid-Size Pharmaceutical Market, by Type - Revenue and Forecast to 2028 (US$ Million)
11.2.5.1.4 Germany: Mid-Size Pharmaceutical Market, by Drug Development Type - Revenue and Forecast to 2028 (US$ Million)
11.2.5.1.5 Germany: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
11.2.5.1.6 Germany: Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
11.2.5.2 France: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.2.5.2.1 Overview
11.2.5.2.2 France: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.2.5.2.3 France: Mid-Size Pharmaceutical Market, by Type - Revenue and Forecast to 2028 (US$ Million)
11.2.5.2.4 France: Mid-Size Pharmaceutical Market, by Drug Development Type - Revenue and Forecast to 2028 (US$ Million)
11.2.5.2.5 France: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
11.2.5.2.6 France: Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
11.2.5.3 UK: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.2.5.3.1 Overview
11.2.5.3.2 UK: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.2.5.3.3 UK: Mid-Size Pharmaceutical Market, by Type - Revenue and Forecast to 2028 (US$ Million)
11.2.5.3.4 UK: Mid-Size Pharmaceutical Market, by Drug Development Type - Revenue and Forecast to 2028 (US$ Million)
11.2.5.3.5 UK: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
11.2.5.3.6 UK: Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
11.2.5.4 Italy: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.2.5.4.1 Overview
11.2.5.4.2 Italy: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.2.5.4.3 Italy: Mid-Size Pharmaceutical Market, by Type - Revenue and Forecast to 2028 (US$ Million)
11.2.5.4.4 Italy: Mid-Size Pharmaceutical Market, by Drug Development Type - Revenue and Forecast to 2028 (US$ Million)
11.2.5.4.5 Italy: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
11.2.5.4.6 Italy: Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
11.2.5.5 Spain: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.2.5.5.1 Overview
11.2.5.5.2 Spain: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.2.5.5.3 Spain: Mid-Size Pharmaceutical Market, by Type - Revenue and Forecast to 2028 (US$ Million)
11.2.5.5.4 Spain: Mid-Size Pharmaceutical Market, by Drug Development Type - Revenue and Forecast to 2028 (US$ Million)
11.2.5.5.5 Spain: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
11.2.5.5.6 Spain: Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
11.2.5.6 Rest of Europe: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.2.5.6.1 Overview
11.2.5.6.2 Rest of Europe: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.2.5.6.3 Rest of Europe: Mid-Size Pharmaceutical Market, by Type - Revenue and Forecast to 2028 (US$ Million)
11.2.5.6.4 Rest of Europe: Mid-Size Pharmaceutical Market, by Drug Development Type - Revenue and Forecast to 2028 (US$ Million)
11.2.5.6.5 Rest of Europe: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
11.2.5.6.6 Rest of Europe: Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
11.3 Asia Pacific: Mid-Size Pharmaceutical Market
11.3.1 Overview
11.3.2 Asia Pacific: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (USD Million)
11.3.3 Asia Pacific: Mid-Size Pharmaceutical Market, By Type, 2019 - 2028 (USD Million)
11.3.3.1 Asia Pacific: Mid-Size Pharmaceutical Market, By Drug Development Type, 2019 - 2028 (USD Million)
11.3.3.2 Asia Pacific: Mid-Size Pharmaceutical Market, By Formulation, 2019 - 2028 (USD Million)
11.3.4 Asia Pacific: Mid-Size Pharmaceutical Market, By Therapy Area, 2019 - 2028 (USD Million)
11.3.5 Asia Pacific: Mid-Size Pharmaceutical Market, by Country, 2022 & 2028 (%)
11.3.5.1 China: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (USD Million)
11.3.5.1.1 China: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (USD Million)
11.3.5.1.2 China: Mid-Size Pharmaceutical Market, By Type, 2019 - 2028 (USD Million)
11.3.5.1.3 China: Mid-Size Pharmaceutical Market, By Drug Development Type, 2019 - 2028 (USD Million)
11.3.5.1.4 China: Mid-Size Pharmaceutical Market, By Formulation, 2019 - 2028 (USD Million)
11.3.5.1.5 China: Mid-Size Pharmaceutical Market, By Therapy Area, 2019 - 2028 (USD Million)
11.3.5.2 Japan: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (USD Million)
11.3.5.2.1 Japan: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (USD Million)
11.3.5.2.2 Japan: Mid-Size Pharmaceutical Market, By Type, 2019 - 2028 (USD Million)
11.3.5.2.3 Japan: Mid-Size Pharmaceutical Market, By Drug Development Type, 2019 - 2028 (USD Million)
11.3.5.2.4 Japan: Mid-Size Pharmaceutical Market, By Formulation, 2019 - 2028 (USD Million)
11.3.5.2.5 Japan: Mid-Size Pharmaceutical Market, By Therapy Area, 2019 - 2028 (USD Million)
11.3.5.3 India: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (USD Million)
11.3.5.3.1 India: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (USD Million)
11.3.5.3.2 India: Mid-Size Pharmaceutical Market, By Type, 2019 - 2028 (USD Million)
11.3.5.3.3 India: Mid-Size Pharmaceutical Market, By Drug Development Type, 2019 - 2028 (USD Million)
11.3.5.3.4 India: Mid-Size Pharmaceutical Market, By Formulation, 2019 - 2028 (USD Million)
11.3.5.3.5 India: Mid-Size Pharmaceutical Market, By Therapy Area, 2019 - 2028 (USD Million)
11.3.5.4 Australia: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (USD Million)
11.3.5.4.1 Australia: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (USD Million)
11.3.5.4.2 Australia: Mid-Size Pharmaceutical Market, By Type, 2019 - 2028 (USD Million)
11.3.5.4.3 Australia: Mid-Size Pharmaceutical Market, By Drug Development Type, 2019 - 2028 (USD Million)
11.3.5.4.4 Australia: Mid-Size Pharmaceutical Market, By Formulation, 2019 - 2028 (USD Million)
11.3.5.4.5 Australia: Mid-Size Pharmaceutical Market, By Therapy Area, 2019 - 2028 (USD Million)
11.3.5.5 South Korea: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (USD Million)
11.3.5.5.1 South Korea: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (USD Million)
11.3.5.5.2 South Korea: Mid-Size Pharmaceutical Market, By Type, 2019 - 2028 (USD Million)
11.3.5.5.3 South Korea: Mid-Size Pharmaceutical Market, By Drug Development Type, 2019 - 2028 (USD Million)
11.3.5.5.4 South Korea: Mid-Size Pharmaceutical Market, By Formulation, 2019 - 2028 (USD Million)
11.3.5.5.5 South Korea: Mid-Size Pharmaceutical Market, By Therapy Area, 2019 - 2028 (USD Million)
11.3.5.6 Rest of Asia Pacific: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (USD Million)
11.3.5.6.1 Rest of Asia Pacific: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (USD Million)
11.3.5.6.2 Rest of Asia Pacific: Mid-Size Pharmaceutical Market, By Type, 2019 - 2028 (USD Million)
11.3.5.6.3 Rest of Asia Pacific: Mid-Size Pharmaceutical Market, By Drug Development Type, 2019 - 2028 (USD Million)
11.3.5.6.4 Rest of Asia Pacific: Mid-Size Pharmaceutical Market, By Formulation, 2019 - 2028 (USD Million)
11.3.5.6.5 Rest of Asia Pacific: Mid-Size Pharmaceutical Market, By Therapy Area, 2019 - 2028 (USD Million)
11.4 Middle East & Africa Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028
11.4.1 Overview
11.4.2 Middle East & Africa Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
11.4.3 Middle East & Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)
11.4.4 Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Drug Development Type (US$ Million)
11.4.4.1 Middle East & Africa: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
11.4.4.2 Middle East & Africa: Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
11.4.5 Middle East & Africa Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Country (%)
11.4.5.1 UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
11.4.5.1.1 Overview
11.4.5.1.2 UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
11.4.5.1.3 UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)
11.4.5.1.4 UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028, By Drug Development Type (US$ Million)
11.4.5.1.5 UAE: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
11.4.5.1.6 UAE: Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
11.4.5.2 Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
11.4.5.2.1 Overview
11.4.5.2.2 Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
11.4.5.2.3 Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)
11.4.5.2.4 Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028, By Drug Development Type (US$ Million)
11.4.5.2.5 Saudi Arabia: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
11.4.5.2.6 Saudi Arabia: Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
11.4.5.3 South Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
11.4.5.3.1 Overview
11.4.5.3.2 South Africa Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
11.4.5.3.3 South Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)
11.4.5.3.4 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Drug Development Type (US$ Million)
11.4.5.3.5 South Africa: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
11.4.5.3.6 South Africa: Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
11.4.5.4 Rest of Middle East and Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
11.4.5.4.1 Overview
11.4.5.4.2 Rest of Middle East and Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
11.4.5.4.3 Rest of Middle East & Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)
11.4.5.4.4 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts To 2028, By Drug Development Type (US$ Million)
11.4.5.4.5 Rest of Middle East and Africa: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
11.4.5.4.6 Rest of Middle East and Africa: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
11.5 South & Central America: Mid-Size Pharmaceutical Market
11.5.1 Overview
11.5.2 South and Central America: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (USD Million)
11.5.3 South and Central America: Mid-Size Pharmaceutical Market, by Type, 2019 - 2028 (USD Million)
11.5.4 South and Central America: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019 - 2028 (USD Million)
11.5.5 South and Central America: Mid-Size Pharmaceutical Market, by Formulation, 2019 - 2028 (USD Million)
11.5.6 South and Central America: Mid-Size Pharmaceutical Market, by Therapy Area, 2019 - 2028 (USD Million)
11.5.7 South and Central America: Mid-Size Pharmaceutical Market, by country, 2021 & 2028 (%)
11.5.7.1 Brazil: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (USD Million)
11.5.7.1.1 Brazil: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (USD Million)
11.5.7.1.2 Brazil: Mid-Size Pharmaceutical Market, by Type, 2019 - 2028 (USD Million)
11.5.7.1.3 Brazil: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019 - 2028 (USD Million)
11.5.7.1.4 Brazil: Mid-Size Pharmaceutical Market, by Formulation, 2019 - 2028 (USD Million)
11.5.7.1.5 Brazil: Mid-Size Pharmaceutical Market, by Therapy Area, 2019 - 2028 (USD Million)
11.5.7.2 Argentina: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (USD Million)
11.5.7.2.1 Argentina: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (USD Million)
11.5.7.2.2 Argentina: Mid-Size Pharmaceutical Market, by Type, 2019 - 2028 (USD Million)
11.5.7.2.3 Argentina: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019 - 2028 (USD Million)
11.5.7.2.4 Argentina: Mid-Size Pharmaceutical Market, by Formulation, 2019 - 2028 (USD Million)
11.5.7.2.5 Argentina: Mid-Size Pharmaceutical Market, by Therapy Area, 2019 - 2028 (USD Million)
11.5.7.3 Rest of South and Central America: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (USD Million)
11.5.7.3.1 Rest of South and Central America: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (USD Million)
11.5.7.3.2 Rest of South and Central America: Mid-Size Pharmaceutical Market, by Type, 2019 - 2028 (USD Million)
11.5.7.3.3 Rest of South and Central America: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019 - 2028 (USD Million)
11.5.7.3.4 Rest of South and Central America: Mid-Size Pharmaceutical Market, by Formulation, 2019 - 2028 (USD Million)
11.5.7.3.5 Rest of South and Central America: Mid-Size Pharmaceutical Market, by Therapy Area, 2019 - 2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Mid-Size Pharmaceutical Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12.5 South and Central America: Impact Assessment of COVID-19 Pandemic
13. Mid-Size Pharmaceutical Market - Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 DAIICHI SANKYO COMPANY LIMITED
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Eisai Co., Ltd.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Bausch Health Companies Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Regeneron Pharmaceuticals, Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Sun Pharmaceutical Industries Ltd
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Alexion Pharmaceuticals, Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Mallinckrodt
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Endo Pharmaceuticals Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Les Laboratories Servier
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 UCB S.A.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Publisher
15.2 Glossary of Terms
List of Tables
Table 1. North America Mid-Size Pharmaceutical Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Mid-Size Pharmaceutical Market, by Drug Development Type - Revenue and Forecast to 2028 (USD Million)
Table 3. North America Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
Table 5. US Mid-Size Pharmaceutical Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 6. US Mid-Size Pharmaceutical Market, by Drug Development Type - Revenue and Forecast to 2028 (US$ Million)
Table 7. US Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
Table 8. US Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada: Mid-Size Pharmaceutical Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Mid-Size Pharmaceutical Market, by Drug Development Type - Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico: Mid-Size Pharmaceutical Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Mid-Size Pharmaceutical Market, by Drug Development Type - Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
Table 17. Europe: Mid-Size Pharmaceutical Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 18. Europe: Mid-Size Pharmaceutical Market, by Drug Development Type - Revenue and Forecast to 2028 (US$ Million)
Table 19. Europe: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
Table 20. Europe: Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
Table 21. Germany: Mid-Size Pharmaceutical Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 22. Germany: Mid-Size Pharmaceutical Market, by Drug Development Type - Revenue and Forecast to 2028 (US$ Million)
Table 23. Germany: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
Table 24. Germany: Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
Table 25. France: Mid-Size Pharmaceutical Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 26. France: Mid-Size Pharmaceutical Market, by Drug Development Type - Revenue and Forecast to 2028 (US$ Million)
Table 27. France: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
Table 28. France: Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
Table 29. UK: Mid-Size Pharmaceutical Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 30. UK: Mid-Size Pharmaceutical Market, by Drug Development Type - Revenue and Forecast to 2028 (US$ Million)
Table 31. UK: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
Table 32. UK: Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
Table 33. Italy: Mid-Size Pharmaceutical Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 34. Italy: Mid-Size Pharmaceutical Market, by Drug Development Type - Revenue and Forecast to 2028 (US$ Million)
Table 35. Italy: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
Table 36. Italy: Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
Table 37. Spain: Mid-Size Pharmaceutical Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 38. Spain: Mid-Size Pharmaceutical Market, by Drug Development Type - Revenue and Forecast to 2028 (US$ Million)
Table 39. Spain: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
Table 40. Spain: Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
Table 41. Rest of Europe: Mid-Size Pharmaceutical Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Europe: Mid-Size Pharmaceutical Market, by Drug Development Type - Revenue and Forecast to 2028 (US$ Million)
Table 43. Rest of Europe: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
Table 44. Rest of Europe: Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
Table 45. Asia Pacific: Mid-Size Pharmaceutical Market, By Type - Revenue and Forecast to 2028 (USD Million)
Table 46. Asia Pacific: Mid-Size Pharmaceutical Market, By Drug Development Type - Revenue and forecast to 2028 (USD Million)
Table 47. Asia Pacific: Mid-Size Pharmaceutical Market, By Formulation - Revenue and forecast to 2028 (USD Million)
Table 48. Asia Pacific: Mid-Size Pharmaceutical Market, By Therapy Area - Revenue and Forecast to 2028 (USD Million)
Table 49. China: Mid-Size Pharmaceutical Market, By Type - Revenue and Forecast to 2028 (USD Million)
Table 50. China: Mid-Size Pharmaceutical Market, By Drug Development Type - Revenue and forecast to 2028 (USD Million)
Table 51. China: Mid-Size Pharmaceutical Market, By Formulation - Revenue and Forecast to 2028 (USD Million)
Table 52. China: Mid-Size Pharmaceutical Market, By Therapy Area - Revenue and Forecast to 2028 (USD Million)
Table 53. Japan: Mid-Size Pharmaceutical Market, By Type - Revenue and Forecast to 2028 (USD Million)
Table 54. Japan: Mid-Size Pharmaceutical Market, By Drug Development Type - Revenue and Forecast to 2028 (USD Million)
Table 55. Japan: Mid-Size Pharmaceutical Market, By Formulation - Revenue and Forecast to 2028 (USD Million)
Table 56. Japan: Mid-Size Pharmaceutical Market, By Therapy Area - Revenue and Forecast to 2028 (USD Million)
Table 57. India: Mid-Size Pharmaceutical Market, By Type - Rev
Samples
LOADING...
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- DAIICHI SANKYO COMPANY LIMITED
- Eisai Co., Ltd.
- Bausch Health Companies Inc.
- Regeneron Pharmaceuticals, Inc
- Sun Pharmaceutical Industries Ltd
- Alexion Pharmaceuticals, Inc.
- Mallinckrodt
- Endo Pharmaceuticals Inc.
- Les Laboratories Servier
- UCB S.A.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 203 |
| Published | June 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 690105.2 Million |
| Forecasted Market Value ( USD | $ 1000584.3 Million |
| Compound Annual Growth Rate | 6.4% |
| Regions Covered | Global |
